Metro · IN

GLP-1 telehealth in Indianapolis

Indianapolis is the headquarters of Eli Lilly and a major hub for GLP-1 and dual-agonist clinical research. The metro's clinician supply and the Indiana University School of Medicine produce strong in-state availability.

Top providers serving Indianapolis

NexLife
Flat-rate compounded GLP-1 with full pharmacy disclosure
96
/100
Ro Body
Established brand, dual compounded + brand-name routes
86
/100
Henry Meds
Low entry price, watch the mid-dose upcharges
80
/100

State context: Indiana

Standard telehealth practice; Indiana Medical Licensing Board licensure required.

Eli Lilly's headquarters and manufacturing in Indianapolis produce a slightly higher density of obesity-medicine clinical research presence in the state.

Read the full Indiana state page →